Ophthotech - 48 Year Dividend Yield History | OPHT

Historical dividend payout and yield for Ophthotech (OPHT) since 1971. The current TTM dividend payout for Ophthotech (OPHT) as of February 15, 2019 is $0.00. The current dividend yield for Ophthotech as of February 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.058B $0.210B
Ophthotech Corporation is a biopharmaceutical company. It is focused on developing and commercializing novel therapies for the treatment of diseases of the eye. The Company is developing Fovista and ARC1905, which are under clinical trials, for the treatment of wet AMD. Ophthotech Corporation is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Bio-Techne Corp (TECH) United States $7.237B 48.76